The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

BACKGROUND: The long-term survival in hepatocellullar carcinoma (HCC) patients after transarterial chemoembolization (TACE) remains dismal due to local and/or regional recurrence as well as distant metastasis. The efficacy of sorafenib in advanced HCC has been demonstrated and brought great hope. Re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Qu, Xu-Dong, Chen, Cheng-Shi, Wang, Jian-Hua, Yan, Zhi-ping, Chen, Jie-min, Gong, Gao-quan, Liu, Qin-xin, Luo, Jian-jun, Liu, Lin-xiao, Liu, Rong, Qian, Sheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3411397/
https://ncbi.nlm.nih.gov/pubmed/22721173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-263
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller